Loading insider details...
Beta
Latest Form 4 (May 21, 2026): Grant/Award of 23,940 NMAX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | Newsmax Inc. (NMAX) | Grant/Award | 23,940 | n/a |
| May 14, 2026 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 10,958 | n/a |
| Jan 6, 2026 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 7,189 | $85.0K |
| May 15, 2025 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 15,287 | n/a |
| Apr 4, 2025 | Newsmax Inc. (NMAX) | Grant/Award | 17,500 | n/a |
| Jan 6, 2025 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 25,236 | $80.0K |
| Feb 7, 2024 | Alto Neuroscience, Inc. (ANRO) | Conversion | 588,898 | n/a |
| Feb 5, 2024 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 30,574 | n/a |